RNS Number : 8850F Renalytix PLC 09 November 2022   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

RNS Number : 1206F Renalytix PLC 03 November 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix   to Present at Stifel Healthcare Conference   NEW YORK, NY and SALT LAKE CITY, UT    ̶  November 3, 2022   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will

RNS Number : 7950E Renalytix PLC 31 October 2022   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

RNS Number : 7941E Renalytix PLC 31 October 2022   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

RNS Number : 5791E Renalytix PLC 31 October 2022   Renalytix plc (" Renalytix ", the "Group" or the " Company ")   Renalytix Reports Full Year Fiscal 2022 Results   LONDON and SALT LAKE CITY , October 31, 2022   -  Renalytix plc   (NASDAQ: RNLX),  (LSE : RENX)   an artificial intelligence-enabled

RNS Number : 1692E Renalytix PLC 26 October 2022   Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this

RNS Number : 1684E Renalytix PLC 26 October 2022   Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders

RNS Number : 9479D Renalytix PLC 25 October 2022     Renalytix plc ("Renalytix" or the "Company")   KidneyIntelX   Medicare Update   NEW YORK and SALT LAKE CITY , October 25, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that, building on recently established private payer and

RNS Number : 7880D Renalytix PLC 24 October 2022     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31   NEW YORK and SALT LAKE CITY , October 24, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today

RNS Number : 0165D Renalytix PLC 17 October 2022     KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology   Four presentations, including first clinical utility findings from multi-year real world evidence results from a major